{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:32:52Z","timestamp":1787063572350,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s40265-023-01935-z","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T10:01:29Z","timestamp":1693648889000},"page":"1309-1314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Birch Bark Extract: A Review in Epidermolysis Bullosa"],"prefix":"10.1007","volume":"83","author":[{"given":"Young-A","family":"Heo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"issue":"3","key":"1935_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4103\/idoj.IDOJ_287_18","volume":"10","author":"L Bruckner-Tuderman","year":"2019","unstructured":"Bruckner-Tuderman L. Newer treatment modalities in epidermolysis bullosa. Indian Dermatol Online J. 2019;10(3):244\u201350.","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"1935_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1279-y","volume":"15","author":"AL Bruckner","year":"2020","unstructured":"Bruckner AL, Losow M, Wisk J, et al. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers. Orphanet J Rare Dis. 2020;15(1):1.","journal-title":"Orphanet J Rare Dis"},{"key":"1935_CR3","unstructured":"EB Research Network. EB research network: understanding EB & its classification. 2022. https:\/\/www.eb-researchnetwork.org\/research\/what-is-eb\/. Accessed 2 Aug 2023."},{"key":"1935_CR4","unstructured":"Wounds International. Best practice guidelines for skin and wound care in epidermolysis bullosa. An international consensus. 2017. https:\/\/ern-skin.eu\/wp-content\/uploads\/2020\/08\/Skin-and-wound-care-EB.pdf. Accessed 2 Aug 2023."},{"issue":"1","key":"1935_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13023-021-01811-7","volume":"16","author":"JY Tang","year":"2021","unstructured":"Tang JY, Marinkovich MP, Lucas E, et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2021;16(1):175.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1935_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jdv.18554","volume":"37","author":"E Bourrat","year":"2022","unstructured":"Bourrat E, Taieb C, Marqui\u00e9 A, et al. Burden of caregivers and out-of-pocket expenditures related to epidermolysis bullosa in France. J Eur Acad Dermatol Venereol. 2022;37(1):194\u2013203.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1935_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13023-019-1086-5","volume":"14","author":"K Martin","year":"2019","unstructured":"Martin K, Geuens S, Asche JK, et al. Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines. Orphanet J Rare Dis. 2019;14(1):133.","journal-title":"Orphanet J Rare Dis"},{"key":"1935_CR8","unstructured":"Sumeray M. Development of two topical approaches to wound healing in EB\u2014an update on progress with Oleogel-S10 and AP103 [abstract no. OP81 plus presentation]. Acta Derm Venereal. 2020;100(Suppl. 220):22."},{"key":"1935_CR9","unstructured":"European Medicines Agency. Filsuvez gel (birch bark extract): EU prescribing information. 2022. https:\/\/www.ema.europa.eu\/. Accessed 2 Aug 2023."},{"key":"1935_CR10","unstructured":"Medicines & Healthcare products Regulatory Agency. Filsuvez gel (birch bark extract): UK prescribing information. 2022. https:\/\/products.mhra.gov.uk\/. Accessed 2 Aug 2023."},{"issue":"1","key":"1935_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086147","volume":"9","author":"S Ebeling","year":"2014","unstructured":"Ebeling S, Naumann K, Pollok S, et al. From a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extract. PLoS ONE. 2014;9(1): e86147.","journal-title":"PLoS ONE"},{"issue":"4","key":"1935_CR12","volume":"32","author":"A Schwieger-Briel","year":"2019","unstructured":"Schwieger-Briel A, Ott H, Kiritsi D, et al. Mechanism of Oleogel-S10: a triterpene preparation for the treatment of epidermolysis bullosa. Dermatol Ther. 2019;32(4): e12983.","journal-title":"Dermatol Ther"},{"issue":"1","key":"1935_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/jid.2009.248","volume":"130","author":"U Woelfle","year":"2010","unstructured":"Woelfle U, Laszczyk MN, Kraus M, et al. Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo: a role for the transient receptor potential canonical (subtype) 6. J Investig Dermatol. 2010;130(1):113\u201323.","journal-title":"J Investig Dermatol"},{"issue":"4","key":"1935_CR14","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1021\/acs.jnatprod.6b00027","volume":"79","author":"T Wardecki","year":"2016","unstructured":"Wardecki T, Werner P, Thomas M, et al. Influence of birch bark triterpenes on keratinocytes and fibroblasts from diabetic and nondiabetic donors. J Nat Prod. 2016;79(4):1112\u201323.","journal-title":"J Nat Prod"},{"issue":"7","key":"1935_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1055\/a-0850-0224","volume":"85","author":"A Scheffler","year":"2019","unstructured":"Scheffler A. The wound healing properties of betulin from birch bark from bench to bedside. Planta Med. 2019;85(7):524\u20137.","journal-title":"Planta Med"},{"key":"1935_CR16","doi-asserted-by":"publisher","first-page":"5068969","DOI":"10.1155\/2017\/5068969","volume":"2017","author":"A Schwieger-Briel","year":"2017","unstructured":"Schwieger-Briel A, Kiritsi D, Schempp C, et al. Betulin-based oleogel to improve wound healing in dystrophic epidermolysis bullosa: a prospective controlled proof-of-concept study. Dermatol Res Pract. 2017;2017:5068969.","journal-title":"Dermatol Res Pract"},{"key":"1935_CR17","unstructured":"Gewert S, Kiritsi D, Schumann H, et al. Oleogel-S10 for the treatment of epidermolysis bullosa (EB)\u2014a 4-patient case series [abstract no. P125]. Acta Derm Venereal. 2020;100(Suppl. 220):75\u20136."},{"key":"1935_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/bjd\/ljac001","volume":"188","author":"JS Kern","year":"2023","unstructured":"Kern JS, Sprecher E, Fernandez MF, et al. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa\u2014results from the phase 3, randomised, double-blind phase of the \u2018EASE\u2019 study. Br J Dermatol. 2023;188:12\u201321.","journal-title":"Br J Dermatol"},{"issue":"350","key":"1935_CR19","first-page":"1","volume":"20","author":"JS Kern","year":"2019","unstructured":"Kern JS, Schwieger-Briel A, L\u00f6we S, et al. Oleogel-S10 phase 3 study \u201cEASE\u201d for epidermolysis bullosa: study design and rationale. Trials. 2019;20(350):1\u201313.","journal-title":"Trials"},{"key":"1935_CR20","doi-asserted-by":"crossref","unstructured":"Murrell DF, Bruckner A, Sprecher E, et al. Oleogel-S10 (birch triterpenes) in the treatment of epidermolysis bullosa wounds: 24-month efficacy and safety data from the EASE study [abstract no. BG04]. Br J Dermatol. 2023;188(Suppl. 4):ljad113.44.","DOI":"10.1093\/bjd\/ljad113.144"},{"key":"1935_CR21","unstructured":"Food and Drug Administration. Epidermolysis bullosa: developing drugs for treatment of cutaneous manifestations\u2014guidance for industry. 2019. https:\/\/www.fda.gov\/. Accessed 2 Aug 2023."},{"issue":"4","key":"1935_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jdv.13953","volume":"31","author":"SV Jain","year":"2017","unstructured":"Jain SV, Harris AG, Su JC, et al. The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa. J Eur Acad Dermatol Venereol. 2017;31(4):692\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1935_CR23","doi-asserted-by":"crossref","unstructured":"Murrell DF, Bruckner A, Davis C, et al. Correlation between wound burden and procedural pain in patients with EB \u22654 years of age: an exploratory analysis from the EASE study [abstract no. 34650 plus poster]. J Am Acad Dermatol. 2022;87(3 Suppl.):AB152.","DOI":"10.1016\/j.jaad.2022.06.641"},{"key":"1935_CR24","unstructured":"Kiritsi D, Murrell DF, Sprecher E, et al. EASE study demonstrates efficacy of Oleogel-S10 (birch triterpenes) on wound healing and pain in the pediatric epidermolysis bullosa population [abstract no. O012]. Pediatr Dermatol. 2022;39(Suppl. 1):9."},{"key":"1935_CR25","unstructured":"National Institute for Health and Care Excellence. Birch bark extract for treating skin wounds associated with dystrophic and junctional epidermolysis bullosa [ID1505]. 2023. https:\/\/www.nice.org.uk\/guidance\/indevelopment\/gid-ta10654. Accessed 2 Aug 2023."},{"key":"1935_CR26","doi-asserted-by":"crossref","unstructured":"Torres-Pradilla M, \u00c1lvarez E, Novoa M, et al. Oleogel-S10 (birch bark extract) in dystrophic epidermolysis bullosa: a case series evaluating the impact on wound burden over 2 years [abstract no. LB1791]. J Investig Dermatol. 2023;143(9):B34.","DOI":"10.1016\/j.jid.2023.06.175"}],"updated-by":[{"DOI":"10.1007\/s40265-023-01949-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000}}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-023-01935-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T10:38:21Z","timestamp":1695292701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-023-01935-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":26,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1935"],"URL":"https:\/\/doi.org\/10.1007\/s40265-023-01935-z","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"21 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40265-023-01949-7","URL":"https:\/\/doi.org\/10.1007\/s40265-023-01949-7","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The preparation of this review was not supported by any external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Young-A Heo is a salaried employee of Adis International Ltd\/Springer Nature, and declares no relevant conflicts of interest. All authors contributed to the review and are responsible for the article content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship and Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, Consent to participate, Consent to publish, Availability of data and material, Code availability"}}]}}